TABLE 3.
Time course of ND |
mRS > 2 |
||
Odds ratio | Confidence interval | P value | |
ND vs. no ND | |||
AD | 10.22 | 4.07–25.68 | <0.001 |
SD | 15.89 | 2.47–102.14 | 0.004 |
DD | 8.31 | 1.51–45.90 | 0.015 |
ND, neurological deterioration; AD, acute neurological deterioration; SD, subacute neurological deterioration; DD, delayed neurological deterioration; mRS, modified Rankin Scale. Adjusted for age, sex, diabetes mellitus, atrial fibrillation, antithrombotics, admission systolic blood pressure (SBP), National Institutes of Health Stroke Scale (NIHSS) score, occlusion site, Trial of Org 10172 in acute stroke treatment (TOAST), the Alberta Stroke Program Early Computed Tomography Score (ASPECTS), procedural time (PT), collateral score, procedural modes, modified Thrombolysis in Cerebral Infarction (mTICI).